Related Experiment Videos
The SSRI antidepressants: exploring their "other" possible properties
Journal of Affective Disorders
|June 3, 1998
Summary
Selective serotonin reuptake inhibitors (SSRIs) may reduce irritability, neuroticism, and worry, potentially offering benefits beyond antidepressant effects. These findings suggest SSRIs could act as "antiworry" agents, improving mood regulation.
Area of Science:
- Psychopharmacology
- Clinical Psychology
Background:
- Selective serotonin reuptake inhibitors (SSRIs) are primarily known for antidepressant and anti-obsessional effects.
- Anecdotal evidence suggests SSRIs may influence other variables related to depression.
- This study explored potential non-antidepressant effects of SSRIs.
Purpose of the Study:
- To investigate whether SSRIs modify variables associated with the onset and maintenance of depression.
- To identify specific psychological constructs that improve with SSRI treatment.
Main Methods:
- A retrospective study involving 53 subjects who reported significant clinical benefit from SSRI treatment.
- Participants completed questionnaires to assess changes in various psychological constructs.
Main Results:
- Significant improvements were observed in scores for irritability, trait depression, worry, and neuroticism.
- Cognitive style components also showed marked positive changes.
- No evidence of response bias was found across all assessed constructs.
Conclusions:
- SSRIs may function as "antiworry" agents, reducing irritability, neuroticism, and maladaptive attributions.
- These effects could be clinically beneficial, potentially reducing the recurrence and duration of depressive episodes by mitigating anxious worry.